These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38594947)

  • 21. Advances in Machine Learning Processing of Big Data from Disease Diagnosis Sensors.
    Lu S; Yang J; Gu Y; He D; Wu H; Sun W; Xu D; Li C; Guo C
    ACS Sens; 2024 Mar; 9(3):1134-1148. PubMed ID: 38363978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment.
    Zhang C; Xu J; Tang R; Yang J; Wang W; Yu X; Shi S
    J Hematol Oncol; 2023 Nov; 16(1):114. PubMed ID: 38012673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiome, big data and machine learning to promote precision medicine for cancer.
    Cammarota G; Ianiro G; Ahern A; Carbone C; Temko A; Claesson MJ; Gasbarrini A; Tortora G
    Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):635-648. PubMed ID: 32647386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of big data technology and its application in cancer care.
    Xiao T; Kong S; Zhang Z; Hua D; Liu F
    Comput Biol Med; 2024 Jun; 176():108577. PubMed ID: 38739981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
    Li J; Li L; You P; Wei Y; Xu B
    Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innovations in Genomics and Big Data Analytics for Personalized Medicine and Health Care: A Review.
    Hassan M; Awan FM; Naz A; deAndrés-Galiana EJ; Alvarez O; Cernea A; Fernández-Brillet L; Fernández-Martínez JL; Kloczkowski A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology.
    Shao J; Ma J; Zhang Q; Li W; Wang C
    Semin Cancer Biol; 2023 Jun; 91():1-15. PubMed ID: 36801447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncolytic Viruses in the Era of Omics, Computational Technologies, and Modeling: Thesis, Antithesis, and Synthesis.
    Menotti L; Vannini A
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digital Transformation of Cancer Care in the Era of Big Data, Artificial Intelligence and Data-Driven Interventions: Navigating the Field.
    Papachristou N; Kotronoulas G; Dikaios N; Allison SJ; Eleftherochorinou H; Rai T; Kunz H; Barnaghi P; Miaskowski C; Bamidis PD
    Semin Oncol Nurs; 2023 Jun; 39(3):151433. PubMed ID: 37137770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future is now? Clinical and translational aspects of "Omics" technologies.
    D'Adamo GL; Widdop JT; Giles EM
    Immunol Cell Biol; 2021 Feb; 99(2):168-176. PubMed ID: 32924178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery.
    Rogers MA; Aikawa E
    Nat Rev Cardiol; 2019 May; 16(5):261-274. PubMed ID: 30531869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial Intelligence and Big Data in Diabetes Care: A Position Statement of the Italian Association of Medical Diabetologists.
    Musacchio N; Giancaterini A; Guaita G; Ozzello A; Pellegrini MA; Ponzani P; Russo GT; Zilich R; de Micheli A
    J Med Internet Res; 2020 Jun; 22(6):e16922. PubMed ID: 32568088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational pharmaceutics - A new paradigm of drug delivery.
    Wang W; Ye Z; Gao H; Ouyang D
    J Control Release; 2021 Oct; 338():119-136. PubMed ID: 34418520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systems and Precision Medicine in Necrotizing Soft Tissue Infections.
    Martins Dos Santos VAP; Hardt C; Skrede S; Saccenti E
    Adv Exp Med Biol; 2020; 1294():187-207. PubMed ID: 33079370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precision medicine and artificial intelligence: overview and relevance to reproductive medicine.
    Hajirasouliha I; Elemento O
    Fertil Steril; 2020 Nov; 114(5):908-913. PubMed ID: 33160512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative toxicogenomics: Advancing precision medicine and toxicology through artificial intelligence and OMICs technology.
    Singh AV; Chandrasekar V; Paudel N; Laux P; Luch A; Gemmati D; Tisato V; Prabhu KS; Uddin S; Dakua SP
    Biomed Pharmacother; 2023 Jul; 163():114784. PubMed ID: 37121152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of artificial intelligence in lung cancer: Rise of the machine.
    Ladbury C; Amini A; Govindarajan A; Mambetsariev I; Raz DJ; Massarelli E; Williams T; Rodin A; Salgia R
    Cell Rep Med; 2023 Feb; 4(2):100933. PubMed ID: 36738739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial Intelligence-Driven Radiomics in Head and Neck Cancer: Current Status and Future Prospects.
    Alabi RO; Elmusrati M; Leivo I; Almangush A; Mäkitie AA
    Int J Med Inform; 2024 Aug; 188():105464. PubMed ID: 38728812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Registries, Databases and Repositories for Developing Artificial Intelligence in Cancer Care.
    Wang JW; Williams M
    Clin Oncol (R Coll Radiol); 2022 Feb; 34(2):e97-e103. PubMed ID: 34922797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.